3 best performing ASX shares in the week of 19 September 2022

Marc Kennis Marc Kennis, September 26, 2022

Best performing ASX shares

The 3 best performing ASX shares in the week of 19 September 2022 were Artemis Resources (ASX:ARV), up 29.7%, Micro-X (ASX:MX1), up 25.9%, and Apollo Tourism & Leisure (ASX:ATL), up 20.2%.

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Artemis Resources (ASX:ARV)

Industry: Resources

Artemis Resources Limited (ARV) is a mineral resource exploration company, focusing on gold, antimony and base metals projects, as well as, rare element and uranium projects.

Market Cap: $67m

12 month high / low: $0.024 – $0.11

 

Artemis Resources

 

 

2. Micro-X (ASX:MX1)

Industry: Healthcare

Micro-X Limited (MX1) is an Australian hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology.

Market Cap: $79m

12 month high / low: $0.11 – $0.35

 

Micro-X

 

 

3. Apollo Tourism & Leisure (ASX:ATL)

Industry: Consumer Cyclicals

Apollo Tourism & Leisure Ltd (ATL) is a multinational company involved in the manufacture, wholesale and retail of a broad range of RVs such as motorhomes, campervans, and caravans. Apollo’s rental activities are generated from 36 central locations across Australia, New Zealand, North America and Europe.

Market Cap: $122m

12 month high / low: $0.365 – $0.80

 

Apollo Tourism & Leisure

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY26

Recent Posts

Imricor

Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now

FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic…

nuclear energy

How Nuclear Energy Became the World’s Most Feared Energy Source

Why Nuclear Energy Still Scares Us and What Really Went Wrong Many investors may remember periods when nuclear energy captured…